相关实验视频
Updated: Jun 17, 2025

05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
21.9K
针对急性下肢缺血症的组织等离子素激活剂血栓溶解的禁忌
Nikita Singh1,2, Tyler Santos3, Ali Basil Ali4
1University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Vascular
|August 9, 2024
概括
超导管组织等离子体激活剂 (tPA) 血栓溶解对于急性四肢缺血 (ALI) 患者具有先前的禁忌是安全的. 现代内血管技术允许个性化治疗,挑战了旧的指导方针.
科学领域:
- 血管外科 血管外科
- 干预心脏病学 干预心脏病学
- 血管内治疗疗法 血管内疗法
背景情况:
- 之前的试验证实了跨导管组织等离子体激活剂 (tPA) 对急性四肢缺血症 (ALI) 的有效性.
- 基于较旧的试验数据,在ALI中存在tPA的确定的禁忌.
- 内血管技术的进步需要对这些禁忌进行重新评估.
研究的目的:
- 重新评估tPA在当代ALI治疗中已确定的禁忌的相关性.
- 评估tPA与吸血栓切除术在ALI患者的安全性和有效性,包括那些先前有禁忌的患者.
主要方法:
- 连续接受tPA和吸血栓切除治疗的ALI患者的回顾性分析 (2016年9月至2022年4月).
- 根据STILE试验标准将患者分为禁忌和非禁忌组.
- 群体之间的人口统计数据和出血并发症的比较.
主要成果:
- 24名患者 (32%) 在禁忌组,52人 (68%) 在非禁忌组.
- 群体之间没有显著的人口统计差异.
- 出血并发症的发病率相似 (3在非禁忌组与1在禁忌组;p = .771).
- 在任何一组中都没有观察到截肢.
结论:
- 现代内血管疗法,包括吸血栓切除术的tPA,可以安全地应用于先前确定的禁忌的ALI患者.
- 个性化风险效益评估对于选择内血管再血管化而不是开放手术再血管化至关重要.
- 对于内血管ALI治疗的现有禁忌指南需要更新,以反映当前的技术能力.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
657
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
657
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
381
Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
One of the advantages of...
381
Clot Retraction and Fibrinolysis
5.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.1K

